Recruiting
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
NCT04902703
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States